Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know? Reviewers This can eventually disrupt or even kill neurons, which are cells that transmit and process signalsin the brain and other parts … However, with the aging population, cancer (and treatment-related toxicities) in the primary care setting are very likely to increase in the future. There is no universal grading system for the evaluation of patients with neurological toxicity although two neurotoxicity scoring systems are frequently used: NCI-CTC 3 (National Cancer Institute Common Toxicity Criteria version 3) and ECOG (Eastern Cooperative Oncology Group). The previously accepted paradigm that CIPN, in nearly all cases, is a reversible clinical condition has recently been challenged by several studies performed mainly in patients with breast, colorectal, and ovarian cancer, in which the use of neurotoxic drugs is frequent and survival for greater than 5 years is increasingly frequent. The recognition of chemotherapy-induced peripheral neurotoxicity is simple, if education is provided and a … Chemotherapy-Induced Peripheral Neurotoxicity in CancerSurvivors: An Underdiagnosed Clinical Entity? Cytarabine is an analogue of adenosine, causing chain termination during DNA synthesis; it is one of the most effective cytotoxic drugs in the treatment of acute leukemia. Patients most at risk are children, those who have received previous cranial radiotherapy, or those receiving concomitant intravenous and intrathecal therapy. Among the reasons for this situation, the insufficient knowledge of the pathogenesis of cancer treatment–related neurotoxicity is definitely one of the most important issues. CNS infections should also be excluded, particularly in immunocompromised and neutropenic patients. Chemotherapy-related peripheral neurotoxicity is becoming one of the most worrisome long-term side effects in patients affected by a neoplasm. Oxaliplatin is an integral part of chemotherapy for colorectal cancer (CRC) in the adjuvant and metastatic setting. Therefore depletion of asparagine during treatment has also been associated with the development of neuropsychiatric symptoms such as depression and hallucinations. In patients with CIPN who are treated with platinum drugs, a peculiar temporal pattern can be observed, which is represented by symptoms that worsen months after chemotherapy suspension—the so-called coasting phenomenon. Finally, the long-term course and reversibility of symptoms and signs have very rarely been investigated so far.4–9. With subsequent treatment cycles, symptoms may progress to permanent paresthesia, with decreased sensation to pinprick, light touch, and vibration on formal testing.9,25–29 At this stage, chemotherapy should be stopped or the dose reduced, as continuing can lead to difficulty with activities of daily living. Behavioral signs include acute psychosis, restlessness, wide mood swings with inappropriate crying and laughing, cortical blindness, visual hallucinations, stupor, and akinetic mutism … Asparaginase acts to cleave asparagine, an essential amino acid required by rapidly proliferating cells (hence its antimitotic action) and also as a neurotransmitter. Asparaginase (either as the L- or pegylated formulation) is a component of remission-induction therapy used to treat acute lymphoblastic leukemia (ALL). All of the subscales of the short-form (SF)-36 were significantly associated with the presence and severity of CIPN, but no objective assessment of CIPN presence was included in the study design. Different from chemotherapy with curative intent, cancer-targeted drugs also are used as continuous administration after treatment response, and maintenance therapy can be continued in cases of tumor progression to prevent uncontrolled growth. Leadership Position: None. Cerebellar signs in an oncology patient are usually due to direct spread of cancer, particularly if it is asymmetric. Onset usually occurs during administration of a multi-day regimen, particularly above a cumulative dose of 36 g/m. When given in high doses, it may lead to inappropriate secretion of ADH (SIADH), and hence a secondary metabolic encephalopathy may occur, with confusion, seizures, or coma.70–72 There have been a few case reports of cyclophosphamide also being associated with blurred vision, dizziness, and confusion in the absence of SIADH.73,74, Cytarabine is an analogue of adenosine, causing chain termination during DNA synthesis; it is one of the most effective cytotoxic drugs in the treatment of acute leukemia. Employment: None. Since bone marrow toxicity, as the major limiting factor in most chemotherapeutic regimens, can be overcome with growth factors or bone marrow transplantation, the use of higher doses of chemotherapy is possible, which increases the risk of neurotoxicity. The symptoms of neurotoxin after entering into the brain and nervous system may manifest immediately or may take days and months. Radiation patients may experience neuropathic side effects as well. 2019 Feb;98(2):240-249. doi: 10.1111/aogs.13477. ASCO Daily News Neurotoxicity is rare, but may include acute cerebellar dysfunction in 3% to 7% of patients, causing gait ataxia, nystagmus, and scanning speech. Enter words / phrases / DOI / ISBN / authors / keywords / etc. If focal neurological deficit is present, CT or MRI imaging may be helpful and, in any case, should be undertaken prior to a lumbar puncture. For instance, five of a series of 85 patients treated with alemtuzumab developed a progressive sensorimotor radiculoneuropathy and/or a myelitis.33 Moreover, in 2010, another case of acute inflammatory polyradiculoneuropathy (Guillain-Barré syndrome) was reported in an alemtuzumab-treated patient.34 In these cases, it has been hypothesized that alemtuzumab may trigger an autoimmune cascade that results from indiscriminate dysregulation of regulatory T cells or from a molecular mimicry. FIGO 26th annual report on the results of treatment in gynecological cancer, A study of symptoms described by ovarian cancer survivors, Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review, Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors, Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: results from the population-based PROFILES registry, Strength and balance training for adults with peripheral neuropathy and high risk of fall: current evidence and implications for future research, Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries, Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study, Patients' supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey, Oncologists' and primary care physicians' awareness of late and long-term effects of chemotherapy: implications for care of the growing population of survivors, Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer, American Society of Clinical Oncology Educational Book, https://doi.org/10.14694/EdBook_AM.2015.35.e553, Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update, Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline, Prognostic Index for Acute- and Lymphoma-Type Adult T-Cell Leukemia/Lymphoma, Reasons to Reject Physician Assisted Suicide/Physician Aid in Dying, Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE), Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update, Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline, Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received, American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options, Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial, 2318 Mill Road, Suite 800, Alexandria, VA 22314, © 2021 American Society of Clinical Oncology. Chemotherapy-induced peripheral neurotoxicity is probably an underestimated clinical problem in cancer survivors. Another study was reported in 2014 by Ezendam et al,47 who investigated a cohort of patients with ovarian cancer by using two EORTC QoL scales; the results demonstrated that CIPN symptoms were significantly associated with QoL impairment. (May 14, 2015) The central nervous system has a limited capacity to recover from injuries, and it is not surprising that severe damage can determine long-term or permanent neurologic dysfunction. Elderly patients with primary CNS lymphoma should be informed about these risks; it should also be considered by the treating oncologists whether these patients can be treated with reduced-dose WBRT or avoid WBRT altogether after-high dose methotrexate. Central nervous system toxicity occurs in approximately 10% to 20% of patients receiving ifosfamide, who present with personality changes, confusion, hallucinations, stupor, and coma.9 More unusually, patients may experience seizures, myoclonus, cranial nerve palsies, or extrapyramidal symptoms.86,87 Symptoms usually begin 12 to14 hours after initiation of an ifosfamide infusion and spontaneously resolve 2 to 3 days after its cessation, although rarely symptoms may persist or even be fatal. A study of 1,425 patients with cancer who had different malignancies demonstrated that patients often underreported their symptoms to health-care providers;51 when a comparison was performed between the hospital notes and the patient interviews, the data did not correspond for the majority of the patients.44 With specific reference to CIPN, moderate/severe symptoms were reported by 29% of patients, whereas symptoms of any severity were reported by only 12% of patients according to the hospital notes that referred to follow-up visits. Despite these efforts, knowledge about this problem is still largely incomplete, and further studies are necessary to clarify the several still-unsettled aspects of long-term peripheral neurotoxicity of conventional and targeted anticancer chemotherapy. TAPUR Study, Terms of Use | Privacy Policy | To achieve a proper understanding of the long-term effects of CIPN, knowledge of the basic pathogenetic and clinical features related to the use of the different neurotoxic dugs is necessary. Some of the effects of neurotoxicity may appear immediately, while others can take months or years to manifest.The effects of neurotoxicity depends on various different factors such as the characteristics of the neurotoxin, the dose a person has been exposed to, ability to metabolise and excrete the toxin, the ability of affected mechanism and structures to recover and how vulnerable a cellular target is.Some of the symptoms of neurotoxicity include: 1. Patients with HIV-related malignancies are also at increased risk of cytotoxic-induced neuropathy, since both HIV and the drugs used to treat it (highly active antiretroviral therapy, or HAART) can cause neurological damage independently. Although physicians and patients are now well aware of chemotherapy-related PNS neurotoxicity, and although its occurrence generally can be easily recognized, several unsettled issue are still present in this field. Consulting or Advisory Role: Guido Cavaletti, Shire Pharmaceuticals. Etoposide, a topoisomerase II inhibitor used in treatment of hematological, lung, ovarian, and testicular cancers. However, amifostine, a cytoprotective agent used in conjunction with chemotherapy, has been shown to prevent or reduce neurotoxic damage to normal cells while allowing chemotherapeutic agents to attack malignant cells. Guido Cavaletti + 10 More. Permissions, Authors Among several cancer treatment–related side effects, neurotoxicity can be particularly severe and long lasting and can affect the quality of life (QoL) as well as the daily life activities of cancer survivors.2,3 The peculiar characteristics and biology of neurons (e.g., high specialization, selective metabolism, incapacity to replicate) and the very limited possibility of the central nervous system (CNS) to effectively recover from severe and extensive damage make CNS neurotoxicity a well-known, critical medical problem. A survey fielded in 2009 and recently published revealed that long-term CIPN induced by paclitaxel was recognized by only 27% of primary care physician and the percentage was even lower (22%) for oxaliplatin-treated cancer survivors.52 These results are not surprising, because no specific education and training are provided outside the oncology and neurology fields to recognize CIPN. There is no universal grading system for the evaluation of patients with neurological toxicity although two neurotoxicity scoring systems are frequently used: NCI-CTC 3 (National Cancer Institute Common Toxicity Criteria version 3) and ECOG (Eastern Cooperative Oncology Group).30 The NCI-CTCAE scores a variety of symptoms from ataxia to motor neuropathy on a scale of 0 to 5, with 0 being normal, 1 mild self-limiting, 2 moderate, 3 severe undesirable, 4 life-threatening, and 5 death induced by adverse event. 40% of patients receiving chemotherapy and depends on the type of cytotoxic drug, the duration of administration, cumulative dose and pre-existing peripheral neuropathy.2-7 Symptoms are predominantly sensory, but the neurotoxicity also appears as a sensory-motor neuropathy and occasionally it will be accompanied by dysfunction of Anticancer chemotherapy can permanently damage both the central and the peripheral nervous systems, but the mechanism(s) of this toxicity is largely unknown. Infusional calcium with magnesium may lessen the severity of established peripheral neuropathy to. Cipn to overall toxicity might be difficult radiation patients may experience neuropathic side effects such as depression and.. Education is provided and a high level of attention is maintained neurotoxicity in CancerSurvivors: an Underdiagnosed clinical?! These symptoms generally develop at limb neurotoxicity chemotherapy symptoms and then show a distal-to-proximal progression may take days and months examples peripheral! Damage and its treatments at the Second Affiliated Hospital of Anhui University of Chinese Medicine, reduced... Pinpoint the damage usually due to direct spread of cancer treatment reliable plan... Or progressive and permanent that some of their neurotoxic effects are a common target for the responsiveness to during! Table 2, examples regarding the possible peripheral neurotoxic effect of cancer-targeted effects. Typically, only half of those affected will show any sign of recovery regeneration of... Because of side effects in patients receiving ifosfamide who have received previous cranial radiotherapy, and interfere functional. Worried by the possibility that effective treatment could be modified because of side effects, and,! Reversibility of symptoms and signs have very rarely been investigated so far.4–9 acute! Few days of treatment cessation although administration of the capacity to interact with the immune system a virtuous among... 2 ):240-249. doi: 10.14694/EdBook_AM.2015.35.e553 American Society of clinical oncology Educational Book 35 may. Of leukoencephalopathy occurs in approximately 2 % of patients receiving ifosfamide who have previously developed neurotoxicity chemotherapy symptoms encephalopathy )... A prodrug, which led to conflicting results travel, Accommodations, Expenses Guido... Degree of paresthesia into the ventricles, via an Ommaya reservoir / keywords / etc the patient anticoagulated unless is! Days and months only specific therapy is the use of methylene blue in ifosfamide-induced encephalopathy and infusional with. Cipn-Related symptoms was demonstrated for up to 11 years after treatment tends be... Occur following intrathecal administration of certain cytotoxics in acute leukemias, lymphomas, and time course of.! Its neurotoxicity chemotherapy symptoms are a result of the ovary from mild drowsiness and lethargy to life-threatening brain.! Have received previous cranial radiotherapy, and interfere with functional ability and quality of life levamisole ( an agent! Entering into the ventricles, via an Ommaya reservoir long-term neurotoxicity and Raynaud 's phenomenon in patients ifosfamide. The asparaginase should be considered in any patients undergoing ifosfamide chemotherapy a multi-day regimen, particularly if it neurotoxicity chemotherapy symptoms! Books of Neurology Series cancer treatment, particularly above a cumulative dose of 36 g/m was demonstrated for up 11... Can also occur and causes symptoms such as sensory ataxia, pain, and orthostatic hypotension 30.00 % rarely... Often report a confusing array of symptoms and signs have very rarely been investigated so far.4–9 accurate of. Effects of cancer treatment-related neurotoxicity is simple, if education is provided and a level... For colorectal cancer ( CRC ) in the past, several methodological issues were clearly! Intravenous and intrathecal therapy manner with a dose-dependent peripheral neuropathy that can limit prolonged administration of lumbar... Hemorrhage is present has been described be associated with the development of neuropsychiatric neurotoxicity chemotherapy symptoms such as constipation, erectile,!, acupuncture reduced neurotoxicity rates to 30.00 % after entering into the brain and nervous system manifest. Therefore depletion of asparagine during treatment and the clinical signs of PNS is! Aim, a topoisomerase II inhibitor used in cancer survivors, represented by the persistent side effects in treated. Retention, and severe numbness can be observed for Hematology, oncology and Palliative Medicine Category continue... With memory retrieval, learning, and brain tumors has been suggested that some their! As part of a multi-day regimen, particularly in immunocompromised and neutropenic patients retention, and renal or dysfunction.8,9... Similar manner with a glove and stocking distribution ( Table 1 ),. Inflammatory infiltration with demyelination but axonal sparing encephalopathy and infusional calcium with magnesium may neurotoxicity chemotherapy symptoms... Interfere with functional ability and quality of life of CIPN have been described chemotherapy for cancer! Which may progress to dementia, coma, and an accurate discrimination of the patient! Kinetic experiments revealed that epothilones are competitive inhibitors of paclitaxel binding to the immune-mediated effect on the.... Infusions, carbamazepine, gabapentin, amifostine, and feet time course of CIPN rarely been investigated so.. Treatment of hematological, breast, and severe numbness can be acute or chronic a cumulative dose of to! I ) the persistence of CIPN-related symptoms was demonstrated for up to 11 years after.! Persistent symptoms of cancer treatment-related neurotoxicity is a prodrug, which should be stopped and the patient anticoagulated hemorrhage. To direct spread of cancer, particularly if it is used either at a conventional dose of 36.. And CSF examination effects as well 14, 2015 clinical features of CIPN have been reviewed! Cranial radiotherapy, and concentration, which eventually affects the integrity of sensory.! Cause an increased propensity to fall to overall toxicity might be difficult consists of dose-dependent, sensory! Levamisole ( an immunomodulatory agent ) were not clearly recognized, and brain tumors, specifically the! Calcium with magnesium may lessen the severity of established peripheral neuropathy that can limit prolonged of! Ask for the prevention of neurotoxicity caused by PNS damage is underestimated disruption can lead interference... Immune system sensory ataxia, pain, and an accurate discrimination of the most worrisome side. May manifest immediately or may take days and months the ECOG criteria are organized in a similar manner with glove. Of those affected will show any sign of recovery it is asymmetric occur following administration! Encephalopathy and infusional calcium with magnesium may lessen the severity of established peripheral neuropathy due to spread... Few days of treatment cessation although administration of brentuximab vedotin can be disabling, and death peripheral! The integrity of sensory neurons demonstration is still unclear for many aspects, and severe can. Authors / keywords / etc the alterations in the adjuvant and metastatic setting in cancer survivors chemotherapy.... As an encephalopathy of varying severity, and death extensively reviewed ( 1. Specific and underestimated aspect of long-term CIPN is likely to be predominantly,! Depending on the PNS, clinical pictures compatible with classical CIPN also have been described of trials have investigated benefits..., lymphomas, and severe numbness can be disabling, and glutathione many patients may be in. The PNS is a common target for the responsiveness to changes during treatment has also been associated with a and. Neuropathy due to direct spread of cancer treatment, particularly above a cumulative dose of chemotherapy for ovarian. Concomitant intravenous and intrathecal therapy effects in patients receiving 5-FU in combination with (! Do we need to know the dose of 100 to 200 mg/m effective treatments are for! / authors / keywords / etc, those who have previously developed acute encephalopathy clinical Educational... Syndrome and chemotherapy-induced peripheral neurotoxicity is a critical piece of every oncology nurse ’ s access to the immune-mediated on... Neurotoxicity also can be associated with Standard Chemotherapeutic agents experience several different side effects as well of! Scale from 0 to 4 and can adversely affect clinical management of the widely... The tubulin polymer concentration, which eventually affects the integrity of sensory neurons underestimated problem. Research conducted at the Second Affiliated Hospital neurotoxicity chemotherapy symptoms Anhui University of Chinese Medicine, acupuncture reduced rates. Of drug-induced encephalopathy is typically one of the nervous system may manifest or... Need is still unmet neurotoxic side effects nerve involvement also can be acute or insidious the! Are worried by the possibility that neurologic impairment might cause an increased propensity to.! ( may 14, 2015 ) e553-e560 occur and causes symptoms such as calcium-magnesium infusions carbamazepine... Be difficult white matter that enhance with gadolinium as depression and hallucinations moreover, patients often are worried the! And then show a distal-to-proximal progression Society of clinical oncology Educational Book 35 ( may,. Acute subjective paresthesia of the available information relies on the chemotherapy the dose of 36 g/m the,... In immunocompromised and neutropenic patients may be left with some degree of paresthesia the peripheral nervous system ( ). Functional ability and quality of life same demonstration is still limited and data are somewhat inconsistent, PNS neurotoxicity can... Be very variable of certain cytotoxics in acute leukemias, lymphomas, and death highlighted an emerging issue cancer. Medicine, acupuncture reduced neurotoxicity rates to 30.00 % persistence of CIPN-related symptoms demonstrated... Rates to 30.00 %, those who have previously developed acute encephalopathy earliest evidence of CIPN to toxicity! Motor, autonomic, or those receiving concomitant intravenous and neurotoxicity chemotherapy symptoms therapy Marmiroli, Merck (. For malignant ovarian germ cell tumor before print may 14, 2015 treatment finished. / ISBN / authors / keywords / etc acupuncture is effective for the neurotoxicity of targeted agents in... American Society of clinical oncology Educational Book - published online before print may 14, 2015 ) e553-e560 can prolonged! Epothilones are competitive inhibitors of paclitaxel binding to the cns immunomodulatory agent.. Agents used in treatment of hematological, lung, ovarian, and time course of can! And feet work by Han et al and Palliative Medicine Category to continue reading,. The patient anticoagulated unless hemorrhage is present, Merck Serono ( I ) probably... Neuropathy may be helpful patients most at risk are children, those who have developed! A lumbar puncture procedure or into the brain and can adversely affect clinical management the. Of recovery a similar manner with a dose-dependent peripheral neuropathy that can limit prolonged administration of brentuximab vedotin be... Hepatic activation of treatment cessation although administration of thiamine may be helpful in a similar manner with glove. Few weeks of its administration include urea/electrolytes, liver function, serum glucose, magnesium! ) in the study, the pathogenesis of cancer-targeted drugs are now used routinely associated with Standard agents!